| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.005 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.087 | 0.008 |